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Color Cherenkov imaging of clinical radiation
therapy
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, Anthony Nomezine1, Lesley A. Jarvis3,4, David J. Gladstone1,3,4, Brian W. Pogue1,2,3,4 and

Abstract
Color vision is used throughout medicine to interpret the health and status of tissue. Ionizing radiation used in
radiation therapy produces broadband white light inside tissue through the Cherenkov effect, and this light is
attenuated by tissue features as it leaves the body. In this study, a novel time-gated three-channel camera was
developed for the ﬁrst time and was used to image color Cherenkov emission coming from patients during treatment.
The spectral content was interpreted by comparison with imaging calibrated tissue phantoms. Color shades of
Cherenkov emission in radiotherapy can be used to interpret tissue blood volume, oxygen saturation and major
vessels within the body.

1234567890():,;
1234567890():,;

1234567890():,;
1234567890():,;

Introduction
Color vision has been perhaps the most widely used
diagnostic in medicine, being part of every point-of-care
examination. The human eye can perceive millions of
color shades1, making it one of the best diagnostic devices
that exist, and physicians take advantage of this every day.
In this work, the concept of color imaging of radiotherapy
dose delivery via the Cherenkov effect has been developed
and demonstrated in clinical radiation therapy. The
attenuation and transmission of this light through human
tissues alter the perceived color signal emitted from the
patient’s surface, thereby yielding biological tissue information. While Cherenkov emission has been known to
exist for many decades2,3, this is the ﬁrst in-depth
examination of what could be gained from multiwavelength imaging of this phenomenon in the context of
radiation therapy.
X-rays are widely used to image through tissue, however, until recently, it has not been possible to directly
visualize their interaction within tissue during dose
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deposition. Theory and simulations predict a linear relationship between Cherenkov emission and radiation dose
under speciﬁc conditions4, and therefore Cherenkov light
imaging has provided a tool to image the dose delivery
from high energy X-rays. Time-gated imaging of Cherenkov emission is able to record the dose delivery process
in real-time and visualize radiotherapy treatments from
start to ﬁnish5,6. The ability to view the beam incidence
upon tissue provides an intuitive sense of how to ensure
that daily treatments are being delivered with sufﬁcient
accuracy7,8. To date, the systems developed for Cherenkov
imaging dosimetry have been monochrome intensiﬁed
cameras, and due to the red and near-infrared weighted
emission from tissue9,10, little focus has been given to
in vivo Cherenkov imaging in other wavelength bands.
However, changes in blood content and oxygenation
within a tissue have large effects upon the light emission,
and the spectral changes associated with these are known
to be diagnostic. In this study, a three-sensor camera was
prototyped with a time-gated image intensiﬁer on each
channel to image the color of Cherenkov light emitted
during radiation therapy. As radiation therapy is primarily
delivered from a linear accelerator with short pulses of
radiation, time-gating allowed for detection of this lowintensity signal above background ambient light levels. In
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Fig. 1 Imaging scheme and camera design. Time-resolved imaging of Cherenkov emission from patients, as shown in a, is possible because the
radiation is delivered in 4 ms pulses at a very low duty cycle, and time-gated intensiﬁed cameras can therefore capture the Cherenkov signal and
perform real-time background subtraction (b). Performing color Cherenkov imaging requires time-gating in each color channel, necessitating the
inclusion of three sets of imaging hardware and appropriate beam splitting optics behind the imaging lens, which is realized in c. A detailed
schematic of the custom three-channel camera is highlighted in d

addition to the goal of seeing the true color of Cherenkov
emission from tissue, this work was initiated to explore
the hypothesis that changes in oxygenation and tissue
composition could be detected in the images. A detailed
schematic of the camera assembly developed for this
study is shown in Fig. 1. Following phantom imaging, a
systematic color study was performed and accompanied
by patient imaging, to assess the value of these colors in
characterizing radiotherapy dose delivery.

Results
Derived Cherenkov emission spectra from tissue

Utilizing the available spectra of extinction coefﬁcients
for various biological media in the visible and nearinfrared range11–14 as shown in Fig. 2a, Cherenkov
emission spectra were calculated for both fat and muscle
tissue types with a ﬁxed emission depth of 5 mm using the
following linear combinations of the absorption

coefﬁcient for fatty and muscle tissue:
μTot;Fatty ðλÞ ¼ 0:9μa;Water ðλÞ þ 0:095μa;Fat ðλÞ
þ 0:005μa;Blood ðλÞ

ð1Þ

μTot;Muscle ðλÞ ¼ 0:98μa;Water ðλÞ þ 0:02μa;Blood ðλÞ

ð2Þ

These spectra are shown in Fig. 2b, along with variations in the muscle blood content to 1% and 3%, indicating that Cherenkov emission from fatty tissues
contains a higher proportion of blue light when compared
with that from muscle tissue. Furthermore, by varying the
weight of oxyhemoglobin in the combined blood
absorption coefﬁcient in Eq. 2, the Cherenkov emission
spectrum from muscle tissue with varying levels of oxygenation was extracted (Fig. 2c). This result highlights the
shift in spectral proﬁle towards red-weighted emission for
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Fig. 2 Cherenkov light transport in tissue. The spectrum of light emitted from tissue is predominantly affected by the absorption bands from
oxyhemoglobin, deoxyhemoglobin, water, and lipids, and the overall tissue scattering spectrum, shown in a. The calculated Cherenkov emission from
5 mm depth in fatty (90% fat/9.5% water/0.5% blood (0.25% Hb/0.25% HbO2)) and radiodense (water and blood in varying percentages with equal
weight to Hb and HbO2) tissues are shown in b, whereas biological changes in blood oxygenation in radiodense tissue (2% blood) a will alter the
Cherenkov emission spectrum due to differences in absorption between oxy- and deoxyhemoglobin c. Lastly, varying the depth of emission in
radiodense tissue (2% blood) effects the Cherenkov emission spectrum at the surface (d)

increasing levels of tissue oxygenation. At last, emission
depth was varied from 10 mm to 1 mm for the same
muscle tissue type (Fig. 2d), outlining the depthdependent contributions to the color of Cherenkov
emission at the surface of the tissue, with red-weighting
increasing monotonically with depth.

and a linear ﬁt to these data yielded a strong linear correlation (R2 = 0.96). This result agrees with the perceptual
observation of increasing blood concentration yielding a
redder image, and with the predicted emission spectra
from muscle tissue with varying blood concentrations
shown in Fig. 2b.

Variation in color of Cherenkov emission from tissue
phantoms

Coincidence of color features and anatomical landmarks in
patient images

White light images of a tissue phantom with oxygenated
porcine blood at 1% show an increased red hue, when
compared with 1%, deoxygenated blood as shown in
Fig. 3b, which is reﬂected in the color Cherenkov images.
Notably present is the blue glow around the outer edge of
the phantom contributed by Cherenkov light generated in
the glass, which is also reﬂected in the phantom images
with varying blood concentrations (Fig. 3a). Systematic
alteration of blood concentration in liquid tissue phantoms yielded an appreciable hue shift from blue towards
red as displayed in Fig. 3c, and this effect was quantiﬁed
by analyzing the average color value in each phantom in
the CIE xyY color space overlayed on a chromaticity
diagram. This portrayal in Fig. 3d reveals a nearmonotonic increase in the derived luminance parameter
x with increasing blood concentration from 0.5% to 3.5%,

Figure 4 shows color Cherenkov images for three
patients who were receiving whole breast radiotherapy
subsequent to their surgical resection for breast cancer.
These images are shown along with corresponding surface
tissue x-ray CT density maps and surface dose maps
extracted from the clinical treatment planning software. It
can be seen from a qualitative comparison of the color
Cherenkov images to the dose maps that the edge of the
Cherenkov emission region corresponds to the edge of the
surface dose distribution, with the contrast between signal
and background in the Cherenkov images provided from
color differences between irradiated and spared tissues. In
addition, anatomical features readily identiﬁable on the
surface CT map such as the nipple-areolar complex,
axillary and periareolar incision scars, and surface vasculature are shown to have reduced red channel intensity
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Fig. 3 Color change of cherenkov emission with varying tissue parameters. Varying blood concentration in aqueous solutions containing 1%
intralipid to mimic tissue scatter impacts the color of Cherenkov emission from the samples, shown in a under irradiation with a 6 MV X-ray beam. In
addition, increased oxygenation increases the signal in the red channel of the Cherenkov images shown in b due to the decreased absorption of red
light by oxyhemoglobin compared with deoxyhemoglobin. Systematic variation of the blood concentration in small samples of 1% intralipid solution
in c shows a near-monotonic distribution of colors along the red-to-blue axis when overlaid on a CIE chromaticity diagram in the xyY color space (d)

in corresponding regions of the color Cherenkov images,
highlighting in vivo color variations in Cherenkov emission from different surface-level tissue types, in agreement
with derived spectral predictions and phantom observations. As both Cherenkov and the background signal are
shown together in color, it is worth noting that certain
features such as the nipple are visible both with roomlight illumination and from Cherenkov emission. Figure
S1 shows the raw images acquired for each patient prior
to color correction, highlighting the differences in room
lighting between the ﬁrst two patients (Fig. 4a, b) and the
third (Fig. 4c).

Discussion
This work presents a novel demonstration of threechannel color imaging of Cherenkov emission, both in
phantoms and in vivo during patient treatment. Presented
in this work is both the prediction and veriﬁcation that
Cherenkov emission spectral characteristics are altered by
varying tissues, and this effect manifests as perceptible
color changes in a biologically relevant range of parameters. Previous studies have shown that monochrome,
red-weighted Cherenkov imaging is able to provide contrast for surface-level anatomical features and is sensitive
to tissue density7,15, and here it is shown that this concept
can be extended to three-channel color images. The
images in Fig. 4 show that various tissue features manifest

not only with varying intensities, as previously demonstrated, but with unique spectral signatures. Combining
spatially resolved color information from Cherenkov
images with reﬂectance- and/or tissue density-based will
allow for more accurate Cherenkov-to-dose conversion
models for in vivo surface dosimetry15,16. This increased
sensitivity to these features may also contribute to more
accurate day-to-day position tracking of the patient setup,
and the novel addition of biological information such as
sensitivity to blood volume and oxygenation can inform
clinicians about physiologic responses to therapy, such as
the development of erythema.
Although this technique does require background light
suppression through time-gating to the linac pulses, one
advantage is the ability to acquire useful images without
background subtraction, as the contrast between Cherenkov signal and background is achieved through color
perception. This technique also presents a natural overlay
of Cherenkov light and background signals through
concurrent acquisition and accumulation, allowing for
more realistic visualizations of radiation interaction with
treated tissues.
One primary disadvantage of the described method is
the complexity of the camera design, requiring three
independent intensiﬁed CMOS cameras. In addition,
image analysis and calibration are more involved when
compared with conventional monochrome Cherenkov
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Fig. 4 Coincidence of Cherenkov color variations and surface tissue features. Cherenkov images of whole breast radiotherapy treatment of
three patients a–c, with zoomed-in views below d–f. The outer edge of the radiation ﬁeld delineated by the Cherenkov emission corresponds with
the surface dose distributions extracted from the treatment planning system (j–l). Surface-weighted tissue density maps extracting from the
simulation CT scan (g–i) show high-density features including the nipple-areolar complex, axillary scars, and surface vasculature, which are coincident
with color variations in the corresponding Cherenkov images as highlighted with white arrows

imaging owing to the complex gamma calibration of the
red-green-blue (RGB) image channels.
Future work will include further patient imaging studies, speciﬁcally to investigate the impact of inter-patient
large-scale tissue composition differences on the color of
Cherenkov emission; this would necessitate careful
control over camera position and consistency of treatment room lighting. Furthermore, this initial study only
involved imaging patients with light skin pigmentation
due to the local patient demographics, and it will be
necessary to image a broader spectrum of skin pigmentation levels in future studies. In addition, the use of
three-channel Cherenkov emission sensing will be
investigated as a tool to improve Cherenkov-to-dose
correction factors for patient-speciﬁc small-scale tissue
optical property variations and across larger patient
cohorts.

Materials and methods
Camera components

Each channel of the color camera is composed of an
independent intensiﬁed CMOS (iCMOS) camera
(C-Dose, DoseOptics LLC, Lebanon NH USA) housed in
a three-tube color video camera assembly (JVC, Yokohama, Japan). The red channel was outﬁtted with a redsensitive iCMOS camera, whereas the blue and green
channels contained blue-sensitive iCMOS cameras. The
imaging characteristics and spectral sensitivity of these
cameras have been explored previously17,18. Each camera
was remotely triggered to stray X-rays, allowing for synchronization with and gating to the linear accelerator
pulses19. The beamsplitter assembly of the video camera,
consisting of RGB dichroic beam splitters and bandpass
ﬁlters, allowed for incoming Cherenkov light signals to be
redirected according to wavelength to the appropriate

Alexander et al. Light: Science & Applications (2021)10:226

camera channel resulting in three raw image stacks for
each acquisition. The camera was equipped with a
10–100 mm, f/1.6 zoom lens (JVC, Yokohama, Japan).
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acquired with the room lights turned off inside the
treatment bunker.
Patient imaging

Image acquisition and processing

Images were acquired using the C-Dose Research software (DoseOptics LLC, Lebanon NH USA) in 16-bit raw
format. Temporal and spatial median ﬁltering were
applied and performed on each camera’s FPGA, with
5-frame and 5 × 5-pixel moving windows, respectively.
This step removed the need for additional noise removal
or smoothing in post-processing. Darkﬁeld image stacks
were acquired for 120 frames with the lens cap applied,
and the average darkﬁeld frame was calculated. All postacquisition image analysis was performed in MATLAB
(MathWorks, Natick MA, USA). For a given acquisition
dataset, each of the three image stacks was frame-averaged
and the average darkﬁeld frame was subtracted from each.
Next, using a checkerboard-based geometric calibration,
2D polynomial transformations were applied to the green
and blue images to spatially align the three channels,
resulting in a spatially registered three-channel image.
Color calibration

Color calibration was performed using a standardized
color chart (Spyder Checkr 24, Datacolor, Lucerne,
Switzerland). Images of the color chart were acquired and
ROIs for each color panel were delineated. The resulting
values for each channel were compared with those from
the reference image of the color chart, and a linear ﬁt was
applied. These ﬁt coefﬁcients were then used to color
correct the raw pixel values in the uncorrected color
images for each acquisition.
Phantom design and imaging

For testing the impact of oxygenation on the color of
Cherenkov emission, tissue phantoms were created
using aqueous solutions of whole porcine blood (Lampire Biological Labs, Pipersville PA) and intralipid
(Baxter Inc., Glenview IL) at 1% each in 1 L glass bottles
and glucose oxidase was used to deoxygenate one
sample. In addition, phantoms with varying blood
concentrations were produced to alter the spectral
absorption of Cherenkov light emitted in the tissue.
Aqueous solutions of 1% intralipid porcine blood ranging from 0.5% to 3.5% in steps of 0.5% were placed in
an array of Petri dishes for simultaneous irradiation. All
phantoms were irradiated with 6 MV X-rays at 600 MU
min−1 from a linear accelerator (Clinac 2100CD, Varian
Medical Systems, Palo Alto, CA, USA) with an open
30 × 30 cm2 ﬁeld. Images were acquired at 20 frames
per second from the tripod-mounted color Cherenkov
camera using a pulse duration of 4 µs and a frame
exposure time of 51 ms. All phantom images were

Three whole breast radiotherapy patients were imaged
as part of an IRB-approved clinical study, with patient
consent obtained for acquisition and use of the images.
All three patients were being treated supine on the right
side, and therefore the color Cherenkov camera was
mounted on a tripod and placed against the left wall of the
treatment room, preventing gantry occlusion by the left
anterior oblique and right posterior oblique tangent ﬁelds.
Each patient was treated with 6 MV X-rays, and imaging
settings were identical to those used for phantom imaging. Treatment room lighting conditions were not
changed from the standard lighting levels used, and
background subtraction was not performed.
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